Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

NAFTIDROFURYL - REFERENCE SPECTRUM (N/A)

NAFTIDROFURYL - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Flupentixol impurity F

Flupentixol impurity F

NA

DISCOVER
ARTICAINE HYDROCHLORIDE CRS (200 MG)

ARTICAINE HYDROCHLORIDE CRS (200 MG)

23964-57-0

DISCOVER
ARTICAINE IMPURITY A CRS (20 MG)

ARTICAINE IMPURITY A CRS (20 MG)

NA

DISCOVER
ARTICAINE IMPURITY E CRS (10 MG)

ARTICAINE IMPURITY E CRS (10 MG)

NA

DISCOVER
ZUCLOPENTHIXOL IMPURITY B CRS(10 MG)

ZUCLOPENTHIXOL IMPURITY B CRS(10 MG)

NA

DISCOVER
ACECLOFENAC IMPURITY F CRS (15 MG)

ACECLOFENAC IMPURITY F CRS (15 MG)

100499-89-6

DISCOVER
ACECLOFENAC IMPURITY H CRS (10 MG)

ACECLOFENAC IMPURITY H CRS (10 MG)

1216495-92-9

DISCOVER
METRONIDAZOLE IMPURITY A CRS (15 MG)

METRONIDAZOLE IMPURITY A CRS (15 MG)

696-23-1

DISCOVER
BUPIVACAINE IMPURITY B CRS (20 MG)

BUPIVACAINE IMPURITY B CRS (20 MG)

65797-42-4

DISCOVER
BUPIVACAINE IMPURITY E CRS (20 MG)

BUPIVACAINE IMPURITY E CRS (20 MG)

1330172-81-0

DISCOVER
FINASTERIDE CRS (130 MG)

FINASTERIDE CRS (130 MG)

98319-26-7

DISCOVER